Year |
Citation |
Score |
2019 |
Chang YJ, Xu CL, Cui X, Bassuk AG, Mahajan VB, Tsai YT, Tsang SH. CRISPR Base Editing in Induced Pluripotent Stem Cells. Methods in Molecular Biology (Clifton, N.J.). PMID 31250381 DOI: 10.1007/7651_2019_243 |
0.312 |
|
2019 |
Sancho-Pelluz J, Cui X, Lee W, Tsai YT, Wu WH, Justus S, Washington I, Hsu CW, Park KS, Koch S, Velez G, Bassuk AG, Mahajan VB, Lin CS, Tsang SH. Mechanisms of neurodegeneration in a preclinical autosomal dominant retinitis pigmentosa knock-in model with a Rho mutation. Cellular and Molecular Life Sciences : Cmls. PMID 30976840 DOI: 10.1007/S00018-019-03090-9 |
0.35 |
|
2018 |
Zhang L, Cui X, Jauregui R, Park KS, Justus S, Tsai YT, Duong JK, Hsu CW, Wu WH, Xu CL, Lin CS, Tsang SH. Genetic Rescue Reverses Microglial Activation in Preclinical Models of Retinitis Pigmentosa. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30001913 DOI: 10.1016/J.Ymthe.2018.06.014 |
0.342 |
|
2018 |
Tsai YT, Wu WH, Lee TT, Wu WP, Xu CL, Park KS, Cui X, Justus S, Lin CS, Jauregui R, Su PY, Tsang SH. Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa. Ophthalmology. PMID 29759820 DOI: 10.1016/J.Ophtha.2018.04.001 |
0.354 |
|
2018 |
Wu WH, Tsai YT, Justus S, Cho GY, Sengillo JD, Xu Y, Cabral T, Lin CS, Bassuk AG, Mahajan VB, Tsang SH. CRISPR Repair Reveals Causative Mutation in a Preclinical Model of Retinitis Pigmentosa: A Brief Methodology. Methods in Molecular Biology (Clifton, N.J.). 1715: 191-205. PMID 29188514 DOI: 10.1007/978-1-4939-7522-8_13 |
0.329 |
|
2017 |
Velez G, Tsang SH, Tsai YT, Hsu CW, Gore A, Abdelhakim AH, Mahajan M, Silverman RH, Sparrow JR, Bassuk AG, Mahajan VB. Gene Therapy Restores Mfrp and Corrects Axial Eye Length. Scientific Reports. 7: 16151. PMID 29170418 DOI: 10.1038/S41598-017-16275-8 |
0.363 |
|
2017 |
Koch SF, Duong JK, Hsu CW, Tsai YT, Lin CS, Wahl-Schott CA, Tsang SH. Genetic rescue models refute nonautonomous rod cell death in retinitis pigmentosa. Proceedings of the National Academy of Sciences of the United States of America. PMID 28468800 DOI: 10.1073/Pnas.1615394114 |
0.379 |
|
2016 |
Sengillo JD, Justus S, Tsai YT, Cabral T, Tsang SH. Gene and cell-based therapies for inherited retinal disorders: An update. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. PMID 27862925 DOI: 10.1002/Ajmg.C.31534 |
0.374 |
|
2016 |
Zhang L, Du J, Justus S, Hsu CW, Bonet-Ponce L, Wu WH, Tsai YT, Wu WP, Jia Y, Duong JK, Mahajan VB, Lin CS, Wang S, Hurley JB, Tsang SH. Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration. The Journal of Clinical Investigation. 126: 4659-4673. PMID 27841758 DOI: 10.1172/Jci86905 |
0.382 |
|
2016 |
Wu WH, Tsai YT, Justus S, Lee T, Zhang L, Lin CS, Bassuk AG, Mahajan VB, Tsang SH. CRISPR repair reveals causative mutation in a preclinical model of retinitis pigmentosa. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27203441 DOI: 10.1038/Mt.2016.107 |
0.356 |
|
2015 |
Koch SF, Tsai YT, Duong JK, Wu WH, Hsu CW, Wu WP, Bonet-Ponce L, Lin CS, Tsang SH. Halting progressive neurodegeneration in advanced retinitis pigmentosa. The Journal of Clinical Investigation. 125: 3704-13. PMID 26301813 DOI: 10.1172/Jci82462 |
0.378 |
|
2014 |
Yang J, Li Y, Chan L, Tsai YT, Wu WH, Nguyen HV, Hsu CW, Li X, Brown LM, Egli D, Sparrow JR, Tsang SH. Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. Human Molecular Genetics. 23: 3445-55. PMID 24497574 DOI: 10.1093/Hmg/Ddu053 |
0.311 |
|
2013 |
Davis RJ, Hsu CW, Tsai YT, Wert KJ, Sancho-Pelluz J, Lin CS, Tsang SH. Therapeutic margins in a novel preclinical model of retinitis pigmentosa. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 13475-83. PMID 23946405 DOI: 10.1523/Jneurosci.0419-13.2013 |
0.381 |
|
2012 |
Yang J, Naumann MC, Tsai YT, Tosi J, Erol D, Lin CS, Davis RJ, Tsang SH. Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors. Plos One. 7: e43889. PMID 22970106 DOI: 10.1371/Journal.Pone.0043889 |
0.349 |
|
2012 |
Li Y, Tsai YT, Hsu CW, Erol D, Yang J, Wu WH, Davis RJ, Egli D, Tsang SH. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Molecular Medicine (Cambridge, Mass.). 18: 1312-9. PMID 22895806 DOI: 10.2119/Molmed.2012.00242 |
0.329 |
|
Show low-probability matches. |